Skip to main content

Find Clinical Trials

Home
Conditions
Refractory Extensive Stage Lung Small Cell Carcinoma

Clinical trial condition

Refractory Extensive Stage Lung Small Cell Carcinoma

Explore clinical trials studying Refractory Extensive Stage Lung Small Cell Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Refractory Extensive Stage Lung Small Cell Carcinoma trial results

Active, Not Recruiting

Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer

NCT04607954

Conditions: Platinum-Resistant Lung Small Cell Carcinoma, Platinum-Sensitive Lung Small Cell Carcinoma, Recurrent Extensive Stage Lung Small Cell Carcinoma, +1 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details